Navigation Links
Inovio Pharmaceuticals to Present at 13th Annual BIO CEO & Investor Conference
Date:2/8/2011

BLUE BELL, Pa., Feb. 8, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. J. Joseph Kim, President and CEO, will present a corporate overview on Inovio at the 13th Annual BIO CEO & Investor conference being held in New York February 14-15, 2011.

A live and archived webcast will be accessible on Inovio's website at www.inovio.com.Inovio PresentationWaldorf=Astoria Duke of Windsor RoomFebruary 15, 2011 10:00 am EThttp://bio.org/bioceo/About Inovio Pharmaceuticals, Inc. Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. These SynCon™ vaccines are designed to provide broad cross-strain protection against known as well as newly emergent strains of pathogens such as influenza. These vaccines, in combination with Inovio's proprietary electroporation delivery devices, have been shown to be safe and generate significant immune responses. Inovio's clinical programs include HPV/cervical dysplasia and cancer (therapeutic), avian flu (preventive), and HIV vaccines (both preventive and therapeutic). Inovio is developing universal influenza and other vaccines in collaboration with scientists from the University of Pennsylvania. Other partners and collaborators include Merck, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene deliver
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on Thursday, February 10, 2011
2. Vanda Pharmaceuticals to Announce Fourth Quarter 2010 Financial Results on February 10, 2011
3. Onyx Pharmaceuticals Receives Fast Track Designation for Carfilzomib; Company Initiates Rolling NDA Submission for Accelerated Approval
4. Cadence Pharmaceuticals Announces U.S. Launch and Availability of OFIRMEV™ (acetaminophen) Injection
5. Cempra Pharmaceuticals Profiles the Broad Spectrum and Potent Activity Profile of Solithromycin (CEM-101) at the 5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day
6. Takeda and Zinfandel Pharmaceuticals Sign Licensing Agreement for Alzheimers Disease Biomarker in Combination with Pioglitazone
7. Savient Pharmaceuticals Provides Business Update
8. Anthera Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
9. Anadys Pharmaceuticals Augments Management Team and Board of Directors
10. Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline
11. Onyx Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Fresne, President and CEO of Egenix, Inc. is pleased to ... its Scientific Advisory Committee. Dr. Vagner, a graduate ... performed research at Embl (European Molecular Biology Laboratory) Heidelberg, ... of health and medical research. He is a Research Director ... France , and at the Gustave Roussy ...
(Date:9/16/2014)...   Synthetic Biologics, Inc. (NYSE MKT: ... and drug programs targeting specific pathogens that cause ... the Company,s Investor Day in New ... syndrome (IBS) program, including its novel, oral product ... the keynote presentation, Mark Pimentel , MD, ...
(Date:9/16/2014)... LOUISVILLE, Ky. , Sept. 16, 2014 /PRNewswire/ ... laboratory technologies and products to hospitals, physician office ... announce that, effective October 1, 2014, it will ... in specified hospital market segments and as a ... in the 48 contiguous United States ...
(Date:9/16/2014)... Sept. 16, 2014 In preparation for VARTECH ... -based cybersecurity company focused on authentication and SSO announced ... the ability to generate a OTP through the presentation ... pioneer of user-based RFID authentication, 2FA,s solutions have leveraged ... for many years. RFID authentication is broadly deployed in ...
Breaking Biology Technology:New Appointment to the Scientific Advisory Committee at Egenix, Inc. 2Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 2Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 3LABSCO Secures Alliance With Siemens Healthcare Diagnostics 2LABSCO Secures Alliance With Siemens Healthcare Diagnostics 32FA, Inc. Announces RFID-based One-Time Password (OTP) Authentication 2
... HILL, N.C., June 10 Pharmaceutical companies can,literally ... in the lifetime cash,flows of potential mega-brands. Research ... of a new product. Sales and Marketing teams ... table at which market success is,determined., Best ...
... provide resources to advance Merrimack,s robust pipeline of biologics ... targeting autoimmune disease and cancer, ... focused on the discovery and development of,novel treatments for autoimmune ... in a Series F private equity financing., Existing and ...
... Pharmaceuticals,Inc. and The Leukemia & Lymphoma Society (LLS) ... to advance the development of a treatment,for acute ... contracted with Provid to supply expert,medicinal chemistry services ... (SCOR) grant at the University of Virginia under ...
Cached Biology Technology:Merrimack Pharmaceuticals Raises $60 Million in Private Financing 2The Leukemia & Lymphoma Society and Provid Pharmaceuticals Announce Collaboration on Treatment for Acute Myelogenous Leukemia 2The Leukemia & Lymphoma Society and Provid Pharmaceuticals Announce Collaboration on Treatment for Acute Myelogenous Leukemia 3
(Date:9/16/2014)... chunk of rock hit the Yukatan peninsula near the site ... 100 teratons of TNT. It left a crater more than ... and volcanism are widely accepted to have wiped out the ... But what happened to the plants on which the dinosaurs ... University of Arizona reveals that the meteorite impact that spelled ...
(Date:9/16/2014)... returned to Spain culminating the around the world of ... of how the global ocean works and what is ... the atmosphere is not limited to coastal areas, but ... planet, and it is already affecting the ocean ecosystem. ... CSIC Residence for Researchers in Barcelona, in a congress ...
(Date:9/16/2014)... the salmon-rich waters of Southeast Alaska to the white ... lobster, lumber and tourist towns, coastal residents around the ... environments divide along political lines. That,s a primary finding ... sociologists published this month in the journal Society ... of environment-related differences from place to place to place. ...
Breaking Biology News(10 mins):Meteorite that doomed the dinosaurs helped the forests bloom 2Meteorite that doomed the dinosaurs helped the forests bloom 3The Malaspina Expedition confirms that pollution reaches even the most remote areas of the ocean 2The Malaspina Expedition confirms that pollution reaches even the most remote areas of the ocean 3Politics divide coastal residents' views of environment, UNH research finds 2Politics divide coastal residents' views of environment, UNH research finds 3
... Ohio -- Engineers at Ohio State University have found ... alternative energy resource. The patented process uses eggshells ... produces hydrogen fuel. It also includes a unique method ... the shells, so that the collagen can be used ...
... 2007Analyses conducted by researchers from Universit Lavals Center for ... affected by climate change. In an article to be ... Letters, the international research team led by Universit Laval ... life in Ward Hunt Lake, a body of water ...
... months last spring, the Vanderbilt greenhouse held more members ... known to exist in the wild., This unusual bounty ... Ellis, a doctoral student in the biological sciences department, ... The species is called the giant whorled sunflower, Helianthus ...
Cached Biology News:Engineered eggshells to help make hydrogen fuel 2Engineered eggshells to help make hydrogen fuel 3North America's northernmost lake affected by global warming 2Student study bolsters case for adding a rare sunflower to the endangered species list 2
... optically clear polystyrene with frosted labeling ... for cell counting. 100% integrity tested. ... new product number, created to easily ... no availability yet, please order under ...
Packaging: package with 500 l Patent/trademark/license (electronic): (r) Registered trademark of Molecular Probes...
... VersaDoc MP 4000 System is a ... system capable of supporting a wide ... chemiluminescence, densitometry, and chemiflourescence. Red, ... imaging of multiplexed fluorescent samples, reducing ...
... hydrophobic barrier pen for immunohistochemistry and in ... frozen or paraffin-embedded tissue sections mounted on ... heat-stable, water-repellent barrier that keeps staining reagents ... of reagents when differentially staining two sections ...
Biology Products: